The BuildMarch 16, 2026via NVIDIA Blog
Roche Scales NVIDIA AI Factories Globally to Accelerate Drug Discovery, Diagnostic Solutions and Manufacturing Breakthroughs
Why it matters
Enterprise-scale AI infrastructure deployment signals how Fortune 500 companies are moving beyond pilots to systematic GPU buildouts across core business functions. This is compute capacity becoming a competitive moat in regulated industries.
Key signals
- 3,500+ NVIDIA Blackwell GPUs deployed globally
- Deployment spans R&D, diagnostics, and manufacturing
- Entire value chain integration
- Published by NVIDIA (vendor source)
- March 2026 — recent enterprise deployment
The hook
3,500 NVIDIA Blackwell GPUs. That's what Roche just deployed across drug discovery, diagnostics, and manufacturing—scaling AI infrastructure across the entire pharma value chain.
Roche's new deployment spans more than 3,500 NVIDIA Blackwell GPUs across its worldwide operations and embedded across the entire value chain, massively scaling R&D productivity, next-generation diagnostics and manufacturing efficiencies.
Relevance score:78/100